GO:0006771 riboflavin metabolic process | Genes & Methods

Riboflavin, also known as vitamin B2, is an essential water-soluble vitamin that serves as the precursor for the coenzymes flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). These flavin coenzymes are indispensable for numerous oxidation-reduction reactions in central metabolism, including the tricarboxylic acid cycle, fatty acid beta-oxidation, and oxidative phosphorylation. The Gene Ontology term GO:0006771, riboflavin metabolic process, encompasses all chemical reactions and pathways involving riboflavin, from its biosynthesis in microorganisms and plants to its uptake, transport, and utilization in animals. Research into riboflavin metabolism is important because humans cannot synthesize riboflavin and must obtain it from dietary sources or gut microbiota. Riboflavin deficiency remains a public health concern in many parts of the world and can lead to ariboflavinosis, characterized by sore throat, cheilosis, and anemia. Moreover, inherited disorders of riboflavin transport and metabolism, such as Brown-Vialetto-Van Laere syndrome, highlight the critical role of this pathway in neuromuscular function. In biotechnology, the riboflavin biosynthetic pathway is a model system for metabolic engineering and industrial vitamin production. Understanding the genes and enzymes involved in riboflavin metabolism provides insights into human disease mechanisms and offers targets for therapeutic intervention and biotechnological applications. This article reviews the ontology, molecular mechanisms, key genes, and research methods relevant to GO:0006771, with a focus on how CRISPR-based models can accelerate discovery.

GO:0006771 riboflavin metabolic process is defined as the chemical reactions and pathways involving riboflavin (vitamin B2), the precursor for the coenzymes flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). This biological process includes the biosynthesis of riboflavin from GTP in bacteria, fungi, and plants, as well as the transport, salvage, and interconversion of riboflavin and its coenzyme derivatives in organisms that require it as a vitamin. The term also covers the regulation of riboflavin levels and the enzymatic steps that convert riboflavin into FMN and FAD.

Riboflavin metabolic process is fundamentally important because riboflavin-derived coenzymes FMN and FAD are required for a wide array of metabolic reactions, including energy production, vitamin activation, and antioxidant defense. In humans, impaired riboflavin metabolism or transport leads to clinical disorders that can affect the nervous system, blood, and development. In microorganisms, the pathway is a target for metabolic engineering to produce vitamin B2 industrially. Thus, studying GO:0006771 has direct implications for human health, nutrition, and biotechnology.

The following genes and their protein products are central to riboflavin metabolic process across species, from bacterial biosynthesis to human transport and coenzyme synthesis.

Riboflavin metabolic process is regulated at multiple levels. In bacteria, the riboflavin biosynthetic operon is controlled by FMN riboswitches, which terminate transcription when FMN levels are high. In humans, riboflavin transporters SLC52A1, SLC52A2, and SLC52A3 are regulated by nutritional status and hormones, and their expression is altered in riboflavin deficiency. Riboflavin kinase and FAD synthetase activities are also modulated to maintain cellular FMN and FAD pools. Additionally, riboflavin metabolism intersects with one-carbon metabolism and oxidative stress pathways, which can influence gene expression.

Dietary riboflavin deficiency leads to ariboflavinosis, characterized by sore throat, cheilosis, angular stomatitis, and anemia. Deficiency is common in populations with limited access to dairy products and meat. Riboflavin deficiency can also impair the metabolism of other vitamins, such as niacin and vitamin B6.

Mutations in the riboflavin transporters SLC52A2 and SLC52A3 cause Brown-Vialetto-Van Laere syndrome, a rare neurological disorder with progressive pontobulbar palsy, sensorineural deafness, and respiratory failure. High-dose riboflavin supplementation can improve symptoms, highlighting the importance of early diagnosis.

Altered riboflavin metabolism has been observed in some cancers, and riboflavin deficiency may increase the risk of esophageal and cervical cancer. However, the exact mechanisms remain under investigation.

Riboflavin is a cofactor for enzymes involved in fatty acid oxidation and branched-chain amino acid metabolism. Riboflavin supplementation is used to treat some inborn errors of metabolism, such as multiple acyl-CoA dehydrogenase deficiency.

CRISPR-Cas9 knockout, knock-in, and point mutation models are used to dissect the function of riboflavin metabolism genes. RNA-seq and ribosome profiling can reveal transcriptomic and translational changes upon perturbation.

Mass spectrometry-based metabolomics quantifies riboflavin, FMN, and FAD levels in cells and tissues. Isotope tracing can measure flux through the riboflavin biosynthetic pathway.

In vitro enzyme assays using recombinant RibA, RibB, RibC, RibD, and RibE proteins measure catalytic activity and substrate specificity. Riboflavin kinase and FAD synthetase activities are assayed spectrophotometrically.

Fluorescently tagged riboflavin transporters (RFVT1-3) allow live-cell imaging of subcellular localization. Riboflavin-responsive riboswitches can be used as biosensors in bacteria.

Researchers studying riboflavin metabolic process-related genes often need to determine whether a candidate gene is causally involved in riboflavin homeostasis, transport, or coenzyme synthesis. CRISPR-based models provide a robust way to test these hypotheses by creating precise genetic perturbations in relevant cell types.

GO:0006771 riboflavin metabolic process is a fundamental biological pathway that spans microbial biosynthesis and human nutrition. Its dysregulation leads to serious health conditions, while its manipulation offers opportunities for biotechnology and medicine. CRISPR-based models are powerful tools to uncover the genetic and molecular mechanisms underlying riboflavin metabolism and to develop new therapeutic and industrial applications.